Business
Mesoblast (ASX:MSB) share price jumps 19% on FDA update – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is racing higher on Wednesday after the US FDA granted it a fast track designation for COVID-19 ARDS…
The Mesoblast limited(ASX: MSB) share price has started the day strongly and is racing materially higher.
At the time of writing, the biotechnology company’s shares are up 12% to $4.62. But at one stage they were up as much as 19% to $4.90.
Why is the Mesoblast share price racing higher?
Investors have been buying the company’s shares this morning after the release of a positive announcement relating to its remestemcel-L product.
According to the release, the United States Food and Drug Administration…
-
Noosa News18 hours agoPill checking to resume in Queensland months after government axed funding
-
Business21 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business23 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Noosa News16 hours agoQueensland girl Millie’s fight for life after magnets tore through her bowel